logo
Tradeweb Announces Date for Second Quarter 2025 Financial Results

Tradeweb Announces Date for Second Quarter 2025 Financial Results

Associated Press8 hours ago
NEW YORK--(BUSINESS WIRE)--Jul 3, 2025--
Tradeweb Markets Inc. (Nasdaq: TW), a leading, global operator of electronic marketplaces for rates, credit, equities and money markets, will release financial results for the second quarter of 2025 on Wednesday, July 30, 2025, at approximately 7:00 AM EDT.
In addition, Tradeweb will host a conference call for investors.
A live webcast of the conference call, along with related presentation materials, will be available at https://investors.tradeweb.com/events-and-presentations.
An archived recording of the call will be available afterward at https://investors.tradeweb.com.
About Tradeweb Markets
Tradeweb Markets Inc. (Nasdaq: TW) is a leading, global operator of electronic marketplaces for rates, credit, equities and money markets. Founded in 1996, Tradeweb provides access to markets, data and analytics, electronic trading, straight-through-processing and reporting for more than 50 products to clients in the institutional, wholesale, retail and corporates markets. Advanced technologies developed by Tradeweb enhance price discovery, order execution and trade workflows while allowing for greater scale and helping to reduce risks in client trading operations. Tradeweb serves more than 3,000 clients in more than 85 countries. On average, Tradeweb facilitated more than $2.2 trillion in notional value traded per day over the past four fiscal quarters. For more information, please go to www.tradeweb.com.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of the federal securities laws. Statements related to, among other things, our outlook and future performance, the industry and markets in which we operate, our expectations, beliefs, plans, strategies, objectives, prospects and assumptions and future events are forward-looking statements.
We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. These and other important factors, including those discussed under the heading 'Risk Factors' in the documents of Tradeweb Markets Inc. on file with or furnished to the SEC, may cause our actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. In particular, preliminary average variable fees per million dollars of volume traded and preliminary fixed fees for rates, credit, equities and money markets are subject to the completion of management's final review and our other financial closing procedures and therefore are subject to change. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements contained in this release are not guarantees of future events or performance and future events, our actual results of operations, financial condition or liquidity, and the development of the industry and markets in which we operate, may differ materially from the forward-looking statements contained in this release. In addition, even if future events, our results of operations, financial condition or liquidity, and events in the industry and markets in which we operate, are consistent with the forward-looking statements contained in this release, they may not be predictive of events, results or developments in future periods.
Any forward-looking statement that we make in this release speaks only as of the date of such statement. Except as required by law, we do not undertake any obligation to update or revise, or to publicly announce any update or revision to, any of the forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this release.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250702588859/en/
CONTACT: Media contacts:
Daniel Noonan, Tradeweb
+1 646 767 4677
[email protected]
Savannah Steele, Tradeweb
+1 646 767 4941
[email protected]
Investor contacts:
Ashley Serrao, Tradeweb
+1 646 430 6027
[email protected]
Sameer Murukutla, Tradeweb
+1 646 767 4864
[email protected]
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: SOFTWARE DATA ANALYTICS INTERNET FINANCE PROFESSIONAL SERVICES TECHNOLOGY ELECTRONIC COMMERCE FINTECH
SOURCE: Tradeweb Markets Inc.
Copyright Business Wire 2025.
PUB: 07/03/2025 09:00 AM/DISC: 07/03/2025 09:01 AM
http://www.businesswire.com/news/home/20250702588859/en
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Monte Rosa Announces Publication in Science of Key Insights that Enable Next Generation Molecular Glue Degrader Medicines
Monte Rosa Announces Publication in Science of Key Insights that Enable Next Generation Molecular Glue Degrader Medicines

Yahoo

time21 minutes ago

  • Yahoo

Monte Rosa Announces Publication in Science of Key Insights that Enable Next Generation Molecular Glue Degrader Medicines

Monte Rosa's AI/ML-powered insights dramatically increase targetable protein space for molecular glue degraders, unlocking new opportunities to address previously undruggable therapeutic targets Science, 3 July 2025 BOSTON, July 03, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the publication of groundbreaking new discoveries featured on the cover of Science. The research article, 'Mining the CRBN Target Space Redefines Rules for Molecular Glue-induced Neosubstrate Recognition,' details how Monte Rosa's proprietary artificial intelligence (AI) and machine learning (ML) engine has uncovered a broad range of human proteins potentially accessible to cereblon (CRBN)-based degradation, spanning diverse protein domains and classes. These findings dramatically expand the actionable target space for MGD drug discovery. 'The findings from this landmark publication, featured on the cover of Science, have accelerated our ability to develop first-in-class medicines for historically intractable targets, validating the power of our QuEEN™ discovery engine to create the next generation of molecular glue degrader medicines,' said Sharon Townson, Ph.D., Chief Scientific Officer of Monte Rosa. 'We're already leveraging these insights to advance our growing pipeline of differentiated MGDs and future medicines that have the potential to transform patients' lives.' 'Our cutting-edge approach to MGD discovery integrates internal datasets with geometric deep learning to characterize protein surfaces. We have uncovered new rules of engagement between protein targets, small molecules and E3 ligases such as cereblon that we're actively exploiting via our proprietary QuEEN discovery engine to rationally design exquisitely selective degrader therapies,' said John Castle, Ph.D., Chief Data and Information Officer at Monte Rosa. 'This work not only highlights the flexibility of cereblon but also demonstrates our ability to design MGDs that address previously inaccessible, disease-relevant proteins.' Monte Rosa's QuEEN discovery engine uses custom-built AI/ML algorithms to analyze protein surfaces at unprecedented scale, identifying previously unrecognized surfaces capable of recruiting cereblon for targeted protein degradation. The novel surface features greatly expand the reach of MGDs and redefine the requirements that govern molecular glue-induced target engagement. The paper further details Monte Rosa's proprietary AI and ML approaches that enabled these discoveries, incorporating geometric deep learning to encode protein surface patches and project geometrical features across the proteome to identify complementary structures that can mediate protein-protein interactions. The analysis successfully identified new protein targets amenable to Monte Rosa's drug discovery approach, spanning more than 100 target classes, many of which are currently considered to be inaccessible to small molecule binding. The findings significantly broaden Monte Rosa's potential therapeutic reach in areas including immunology, inflammation and oncology, where the company is currently advancing programs in the clinic. About Monte RosaMonte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. MGDs are small molecule protein degraders that have the potential to treat many diseases that other modalities, including other degraders, cannot. Monte Rosa's QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical libraries, structural biology, and proteomics to rationally design MGDs with unprecedented selectivity. Monte Rosa has developed the industry's leading pipeline of MGDs, which spans autoimmune and inflammatory diseases, oncology, and beyond. Monte Rosa has a global license agreement with Novartis to advance VAV1-directed molecular glue degraders and a strategic collaboration with Roche to discover and develop MGDs against targets in cancer and neurological diseases previously considered impossible to drug. For more information, visit InvestorsAndrew Funderburk ir@ MediaCory Tromblee, Scient PRmedia@ A photo accompanying this announcement is available at in to access your portfolio

Liberty Energy Inc. Announces Timing of Release of Second Quarter 2025 Financial Results and Conference Call
Liberty Energy Inc. Announces Timing of Release of Second Quarter 2025 Financial Results and Conference Call

Business Wire

time23 minutes ago

  • Business Wire

Liberty Energy Inc. Announces Timing of Release of Second Quarter 2025 Financial Results and Conference Call

DENVER--(BUSINESS WIRE)--Liberty Energy Inc. (NYSE: LBRT) announced today that it will release its financial results for the second quarter ending June 30, 2025, after the market closes on Wednesday, July 23, 2025. Following the release, the Company will host a conference call to discuss the results at 8:00 a.m. Mountain Time (10:00 a.m. Eastern Time) on Thursday, July 24, 2025. Presenting the Company's results will be Ron Gusek, President and Chief Executive Officer, and Michael Stock, Chief Financial Officer. Individuals wishing to participate in the conference call should dial (833) 255-2827, or for international callers, (412) 902-6704. Participants should ask to join the Liberty Energy call. A live webcast will be available at The webcast can be accessed for 90 days following the call. A telephone replay will be available shortly after the call and can be accessed by dialing (877) 344-7529, or for international callers (412) 317-0088. The passcode for the replay is 7843160. The replay will be available until July 31, 2025. About Liberty Liberty Energy Inc. (NYSE: LBRT) is a leading energy services company. Liberty is one of the largest providers of completion services and technologies to onshore oil, natural gas, and enhanced geothermal energy producers in North America. Liberty also owns and operates Liberty Power Innovations LLC, providing advanced distributed power and energy storage solutions for the commercial and industrial, data center, energy, and mining industries. Liberty was founded in 2011 with a relentless focus on value creation through a culture of innovation and excellence and the development of next generation technology. Liberty is headquartered in Denver, Colorado. For more information, please visit and or contact Investor Relations at IR@

AM Best Affirms Credit Ratings of Worldwide Reinsurance Limited
AM Best Affirms Credit Ratings of Worldwide Reinsurance Limited

Yahoo

time29 minutes ago

  • Yahoo

AM Best Affirms Credit Ratings of Worldwide Reinsurance Limited

MEXICO CITY, July 03, 2025--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of B+ (Good) and the Long-Term Issuer Credit Rating of "bbb-" (Good) of Worldwide Reinsurance Limited (Worldwide Re) (Trinidad and Tobago). The outlook of these Credit Ratings (ratings) is positive. The ratings reflect Worldwide Re's balance sheet strength, which AM Best assesses as strong, as well as its adequate operating performance, neutral business profile and marginal enterprise risk management (ERM). The positive outlooks reflect Worldwide Re's improvements to its ERM profile through enhancements to its non-proportional retrocession structure and further reinforcement of its corporate governance, which safeguards its strongest risk-adjusted capitalization supportive of a stable balance sheet strength, and sound operating performance. Worldwide Re launched operations in 2013, to provide reinsurance capacity for property, marine and liability lines of business and is diversified geographically throughout Europe, where the majority of its business is currently located, Oceania, Asia, Central America, South America and the Caribbean. Worldwide Re operates through a network of brokers, intermediaries and managing general agents. The ratings also reflect Worldwide Re's good and sustained underwriting quality and profitability, solid capital management and geographically diversified premiums. Partially offsetting these positive rating factors are the highly competitive landscape in its target geographic markets amid a challenging economic environment. The company's capital base has grown consistently over time through reinvestment of earnings, reflecting a compound annual growth rate of 10.5% as of 2024, mainly driven by sound underwriting practices. In 2024, Worldwide Re recorded a combined ratio of 72.7% and a return on equity of 31.4%, enabled by a surge in its growth and well-contained overall expenses, as well as a release of excess reserves. Additionally, AM Best expects future acquisition expenses to offset deviations in claims as the company decreases its risk retention, while expanding consistently in target geographies, along with a good reinsurance security panel. Financial income continues to support Worldwide Re's results; however, the company is not dependent on this revenue to achieve positive bottom-line results. Worldwide Re constantly reviews its underwriting guidelines to improve the performance of its business segments that are deviating from targets. Positive rating actions could occur if the company is able to maintain improvements in its ERM profile, while maintaining its current level of risk-adjusted capitalization supporting a stable balance sheet. Negative rating actions could occur if the company's operating performance deteriorates to a level no longer supportive of the ratings. This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Performance Assessments, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments. AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit Copyright © 2025 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED. View source version on Contacts Salvador Smith, CQF Associate Director, Analytics +52 55 9085 7506 Alfonso Novelo Senior Director, Analytics +52 55 9085 7501 Christopher Sharkey Associate Director, Public Relations +1 908 882 2310 Al Slavin Senior Public Relations Specialist +1 908 882 2318 Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store